Infectious Disease
RSSArticles
-
Dupilumab Injection (Dupixent)
Dupilumab is indicated for the treatment of adults with moderate-to-severe atopic dermatitis (eczema) in whom prescription topical therapies are inadequate or not advisable.
-
How Many Sex Partners Is 'Too Many'?
Changing mores regarding sex have direct bearing on patterns of sexual behavior and frequencies of STDs.
-
Restricting Fluoroquinolone Use Reduces Clostridium difficile Infection More Than Infection Control Methods
An observational study from England showed that restricting fluoroquinolone use reduced incidence of Clostridium difficile infection more than would be predicted by improved infection control methods alone.
-
Bright-light Therapy for Daytime Sleepiness in Parkinson’s Disease Patients
Light therapy has been shown to be beneficial in treating excessive daytime sleepiness in Parkinson’s disease patients and also may improve sleep quality.
-
Pregabalin Not Effective for Reducing Pain in Acute or Chronic Sciatica
An Australian study of 207 patients suffering from acute and chronic clinically diagnosed sciatica did not find that treatment with pregabalin for eight weeks reduced pain at eight or 52 weeks.
-
Is This Fascicular Ventricular Tachycardia?
The ECG in the figure in this story was obtained from a 55-year-old man who presented for emergency care with palpitations and fatigue. His blood pressure was 80/50 mmHg at the time the tracing was recorded. Is this a case of ventricular tachycardia?
-
Clinical Briefs
In this section: treating depression; the subdural risk of antithrombotics; and the health consequences of a poor diet.
-
Ocrelizumab Injection (Ocrevus)
Ocrelizumab is indicated for the treatment of patients suffering from relapsing multiple sclerosis or primary progressive multiple sclerosis.
-
A New Risk Score for Stroke in Atrial Fibrillation
A new, simpler score for stroke risk prediction in atrial fibrillation patients uses biomarkers to supplant many clinical variables and outperforms the CHA2DS2-VASc score in two large cohorts.
-
Treating Erectile Dysfunction After Myocardial Infarction May Be Safe
In a Swedish nationwide cohort study of men < 80 years of age hospitalized for myocardial infarction, treatment for erectile dysfunction with phosphodiesterase-5 inhibitors resulted in lower mortality and heart failure hospitalization.